Altimmune Inc (ALT)
NASDAQ:ALT

Altimmune (ALT) Stock Price & Analysis

1,797 Followers

ALT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.82 - $23.49
Previous Close$4.2
Volume1.20M
Average Volume (3M)2.17M
Market Cap
$210.48M
Enterprise Value$49.11M
Total Cash (Recent Filing)$165.76M
Total Debt (Recent Filing)$4.40M
Price to Earnings (P/E)-2.4
Beta0.27
Aug 15, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.73
Shares Outstanding49,292,189
10 Day Avg. Volume1,469,160
30 Day Avg. Volume2,170,995
Standard Deviation0.47
R-Squared0.00005
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)1.35
Price to Sales (P/S)9858.44
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-621.70
Enterprise Value/Gross Profit-722.27
Enterprise Value/Ebitda-0.55
Forecast
Price Target Upside495.12% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ALT FAQ

What was Altimmune Inc’s price range in the past 12 months?
Altimmune Inc lowest stock price was $3.82 and its highest was $23.49 in the past 12 months.
    What is Altimmune Inc’s market cap?
    Currently, no data Available
    When is Altimmune Inc’s upcoming earnings report date?
    Altimmune Inc’s upcoming earnings report date is Aug 15, 2023 which is in 68 days.
      How were Altimmune Inc’s earnings last quarter?
      Altimmune Inc released its earnings results on May 11, 2023. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.48 by $0.08.
        Is Altimmune Inc overvalued?
        According to Wall Street analysts Altimmune Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Altimmune Inc pay dividends?
          Altimmune Inc pays a Notavailable dividend of $873 which represents an annual dividend yield of N/A. See more information on Altimmune Inc dividends here
            What is Altimmune Inc’s EPS estimate?
            Altimmune Inc’s EPS estimate is -$0.47.
              How many shares outstanding does Altimmune Inc have?
              Altimmune Inc has 49,292,190 shares outstanding.
                What happened to Altimmune Inc’s price movement after its last earnings report?
                Altimmune Inc reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.48. Following the earnings report the stock price went up 7.028%.
                  Which hedge fund is a major shareholder of Altimmune Inc?
                  Among the largest hedge funds holding Altimmune Inc’s share is Ardsley Advisory Partners. It holds Altimmune Inc’s shares valued at 6M.

                    ---

                    Altimmune Stock Smart Score

                    The Altimmune stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Altimmune Inc

                    The Group is development stage company which intend to acquire an operating business, through a merger, capital stock exchange, asset acquisition or other similar business combination. The Group does not have any activities.

                    ---

                    Top 5 ETFs holding ALT

                    Name
                    Market Value
                    Smart Score
                    Vanguard Health Care ETF
                    $863.36K
                    8
                    Picton Mahoney Fortified Long Short Alternative Fund Trust Units
                    $240.72K
                    8
                    iShares NASDAQ US Biotechnology UCITS ETF
                    $102.61K
                    8
                    Picton Mahoney Fortified Active Extension Alternative Fund ETF
                    $42.35K
                    8
                    Invesco Nasdaq Biotechnology ETF
                    $3.82K
                    8
                    Up to five ETFs with an Outperform Smart Score that hold ALT. The ETFs are listed according to market value of ALT within the ETF

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Aptose Biosciences
                    BioCryst
                    CytoDyn
                    Eton Pharmaceuticals

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis